News and Comments

Elan's Choices

  Saturday, April 16, 2011

Biogen Idec (BIIB) announced positive results of a process aimed at Identifying high-risk patients for a life-threatening side effect of prolonged use of the multiple sclerosis drug Tysabri. This test is a necessity because it detects an antibody that points to the presence of the Polyomavirus JC (JC virus), which causes the life-threatening progressive multifocal leukoencephalopathy (PML). This side effect in one per thousand patients has deprived Elan from billions of dollars in expected sales of Tysabri.  More...


Recent Postings


Archive


Tags

Agenus (AGEN) Sanofi (SNA) Aimmune Therapeutics (AIMT) Multiple Myeloma Ridaforolimus Mirati Therapeutics (MRTX) Benlysta (belimumab) Cytokinetics (CYTK) Telaprevir Abbott Laboratories (ABT) Biocryst (BCRX) GUARDIAN HEALTH ImmunoGen (IMGN) Alnylam (ALNY) Intermune (ITMN) Roche (ROCHE) Sequenom (SQNM) SYNTA (SNTA) Theravance Bio Pharma (TBPH) Intrexon (XON) SERES THERAPEUTICS (MCRB) Ariad (ARIA) NEKTAR (NKTR)) SUNESIS PHARMACEUTICALS (SNSS) HALOZYME (HALO) Onyx (ONXX) REGULUS (RGLS) GlaxoSmithKline (GSK) Micromet (MITI) Vertex (VRTX) KITE (KITE) Valeant Pharmaceuticals International (VRX) Seattle Genetics (SGEN) Dynavax (DVAX) Vitae Pharmaceuticals (VTAE) Herceptin Theravance (THRX) Intercept (ICPT) Genentech Velcade (bortezomib) AERIE PHARMACEUTICALS CompuGen (CGEN) Sanofi-Aventis (SAN) Merck (MRK) Ziofpharm (ZIOP) BIOMARIN (BMRN) Revlimid (lenolidamide) Inovio (INO) VANDA (VNDA) Agenus (AGEN IDERA (IDRA) ABBVIE (ABBV) Incyte (INCY) Idenix (IDIX) Dendreon (DNDN) Xoma (XOMA) Jazz Pharmaceuticals (JAZZ) Trastuzumab-DM1 Endometrial Cancer galapagos (GLPG) Zerenex Elan (ELN) Prolor Biotech (PBTH) Roche (RHHBY) ACADIA (ACAD) Regeneron (REGN) Prosensa (RNA) KERYX (KERX) Amgen (AMGN) Ionis (IONS) Array Pharmaceuticals (ARRY) Anadys (ANDS) Biogen Idec (BIIB) NANTKWEST (NK) TOKAI (TKAOI) Sanofi (SNY) JUNO (JUNO) ARCA (ABIO) Pluristem (PSTI) Sangamo (SGMO) ZALTRAP™ C4 Therapeutics ISIS (ISIS) OSI (OSIP) Rapamune Alder Biopharmaceuticals (ALDR) Human Longevity (HLI) Human Genome Sciences (HGSI) Anacor (ANAC) Exelixis (EXEL) Illumina (ILMN) ADVENTRIX (ANX) Tysabri Bristol-Myers Squibb (BMY) Galena (GALE) Auspex (ASPX) Sarepta (SRPT) Gilead (GILD)